IMAGING DIAGNOSTIC SYSTEMS INC /FL/ (IMDS) financial statements (2021 and earlier)

Company profile

Business Address 1291-B NW 65TH PLACE
FORT LAUDERDALE, FL 33309
State of Incorp. FL
Fiscal Year End June 30
SIC 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
Q2
9/30/2020
Q1
6/30/2020
Q4
3/31/2020
Q3
12/31/2019
Q2
9/30/2019
Q1
6/30/2019
Q4
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments0000000
Cash and cash equivalents0000000
Receivables00 0000
Inventory, net of allowances, customer advances and progress billings(0)(0) 0000
Inventory(0)(0) 0000
Prepaid expense0000000
Other undisclosed current assets(0)(0)0(1)(0)(0)(0)
Total current assets:0000000
Noncurrent Assets
Operating lease, right-of-use asset000000 
Property, plant and equipment 000000
Total noncurrent assets:0000000
TOTAL ASSETS:0000000
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:0000000
Accounts payable0000000
Accrued liabilities0000000
Employee-related liabilities0000000
Other undisclosed accounts payable and accrued liabilities(0)(0)(0)(0)(0)(0)(0)
Debt1111100
Due to related parties0      
Other undisclosed current liabilities0000000
Total current liabilities:1111111
Noncurrent Liabilities
Long-term debt and lease obligation000000 
Operating lease, liability000000 
Other undisclosed noncurrent liabilities000    
Total noncurrent liabilities:000000 
Total liabilities:1111111
Temporary equity, carrying amount0000000
Stockholders' equity
Stockholders' equity attributable to parent, including:(2)(2)(2)(1)(1)(1)(1)
Common stock133133133133132132125
Additional paid in capital      7
Accumulated deficit(134)(134)(134)(134)(134)(133)(133)
Other undisclosed stockholders' equity attributable to parent0      
Total stockholders' equity:(2)(2)(2)(1)(1)(1)(1)
TOTAL LIABILITIES AND EQUITY:0000000

Income statement (P&L) ($ in millions)

12/31/2020
Q2
9/30/2020
Q1
6/30/2020
Q4
3/31/2020
Q3
12/31/2019
Q2
9/30/2019
Q1
6/30/2019
Q4
Other income 0     
Gross profit: 0     
Operating expenses(0)(0)(0)(0)(0)(0)(1)
Other undisclosed operating income (loss) (0)0    
Operating loss:(0)(0)(0)(0)(0)(0)(1)
Nonoperating expense(0)(0)(0)(0)(0)(0)(0)
Interest and debt expense(0)(0)(0)(0)(0)(0)(0)
Loss before gain (loss) on sale of properties:(0)(0)(0)(0)(0)(0)(1)
Other undisclosed net income0  00  
Net loss:(0)(0)(0)(0)(0)(0)(1)
Other undisclosed net income attributable to parent 00  00
Net loss attributable to parent:(0)(0)(0)(0)(0)(0)(1)
Preferred stock dividends and other adjustments(0)(0)(0)(0)(0)(0)(0)
Net loss available to common stockholders, diluted:(0)(0)(0)(0)(0)(0)(1)

Comprehensive Income ($ in millions)

12/31/2020
Q2
9/30/2020
Q1
6/30/2020
Q4
3/31/2020
Q3
12/31/2019
Q2
9/30/2019
Q1
6/30/2019
Q4
Net loss:(0)(0)(0)(0)(0)(0)(1)
Comprehensive loss, net of tax, attributable to parent:(0)(0)(0)(0)(0)(0)(1)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: